Fish Oils and Soybean Lecithin Supplementation Modulate Immune Function in Runners
Launched by UNIVERSITY OF SAO PAULO · Nov 30, 2017
Trial Information
Current as of July 04, 2025
Completed
Keywords
ClinConnect Summary
The volunteers were not taking any medication during the study. All individuals signed an informed consent form to the study protocol. Both experimental procedure and informed consent form of this study were in accordance with Guide for the Care and Use of Humans.
All volunteers performed two half-marathons. In the first half-marathon, all participants were not supplemented. Dietary supplementation was initiated immediately after the first race. The volunteers were randomly separated into 3 groups: Soybean lecithin group; Fish oil-DHA group and Fish oil-EPA group. The volunteers ingested 3...
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Healthy recreational half-marathon runners.
- Exclusion Criteria:
- • Auto-immune disease Inflammatory disease Cardiorespiratory disease
About University Of Sao Paulo
The University of São Paulo (USP) is a prestigious public research university located in Brazil, renowned for its commitment to advancing knowledge and innovation in various fields, including medicine and health sciences. As a clinical trial sponsor, USP leverages its extensive academic resources, interdisciplinary expertise, and state-of-the-art facilities to facilitate groundbreaking research aimed at improving patient outcomes and addressing critical health challenges. The university's strong emphasis on ethical standards and regulatory compliance ensures that all clinical trials are conducted with the highest integrity, fostering collaboration among researchers, healthcare professionals, and the broader community to enhance scientific discovery and translate findings into practical applications.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sao Paulo, , Brazil
Patients applied
Trial Officials
Tania C Pithon-Curi, PhD
Principal Investigator
University of Sao Paulo and Cruzeiro do Sul University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials